Blutdruck und Blutdruckregulation
Reference41 articles.
1. Ames RS, Sarau HM, Chambers JK, Willette RN, Alyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, Ao Z, Disa J, Holmes SD, Stadel JM, Martin JD, Liu W-S, Glover GI, Wilson S, McNulty DE, Ellis CE, Eishourbagy NA, Shabon U, Trill JJ, Hay DWP, Ohlstein EH, Bergsma DJ, Douglas SA (1999) Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14, Nature 401:282–286 2. Blacher J, Staessen JA, Girerd X, Gasowski J, Thijs L, Liu L, Wang JG, Fagard RH, Safar ME (2000) Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med 160:1085–1089 3. Chao J, Stallone JN, Liang Y-M, Chen L-M, Wang D-Z, Chao L (1997) Kallistatin is a new vasodilator. J Clin Invest 100:11–17 4. Cheung BM, Brown MJ (1994) Plasma brain natriuretic peptide and C-type natriuretic peptide in essential hypertension. J Hypertension 12:449–454 5. Clozel M, Breu V, Burri K, Cassai JM, Fischii W, Gray GA, Hirth G, Löffler BM, Müller M, Neidhart W, Ramuz H (1993) Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 365:759–761
|
|